Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care.

Humans Cognitive Dysfunction / diagnosis Alzheimer Disease / diagnosis Life Style Cognition Primary Health Care
Alzheimer's cognitive assessment dementia detection

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
09 2023
Historique:
revised: 24 01 2023
received: 09 12 2022
accepted: 25 01 2023
medline: 15 9 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Mild cognitive impairment remains substantially underdiagnosed, especially in disadvantaged populations. Failure to diagnose deprives patients and families of the opportunity to treat reversible causes, make necessary life and lifestyle changes and receive disease-modifying treatments if caused by Alzheimer's disease. Primary care, as the entry point for most, plays a critical role in improving detection rates. We convened a Work Group of national experts to develop consensus recommendations for policymakers and third-party payers on ways to increase the use of brief cognitive assessments (BCAs) in primary care. The group recommended three strategies to promote routine use of BCAs: providing primary care clinicians with suitable assessment tools; integrating BCAs into routine workflows; and crafting payment policies to encourage adoption of BCAs. Sweeping changes and actions of multiple stakeholders are necessary to improve detection rates of mild cognitive impairment so that patients and families may benefit from timely interventions.

Identifiants

DOI: 10.1002/alz.13051 PMID: 37073874
pubmed: 37073874
doi: 10.1002/alz.13051
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4252-4259

Informations de copyright

© 2023 UsAgainstAlzheimer's. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

American Academy of Neurology. AAN summary of practice guideline for clinicians: mild cognitive impairment. 2017. https://www.aan.com/Guidelines/home/GetGuidelineContent/882
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment. Neurol. 2018;90(3):126-135. https://doi.org/10.1212/WNL.0000000000004826
Alzheimer's Association. 2021 Alzheimer's disease facts and figures: special report: race, ethnicity and Alzheimer's in America. 2021. Last accessed December 2022: https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf
El-Hayek YH, Wiley RE, Khoury CP, et al. Tip of the iceberg: assessing the global socioeconomic costs of Alzheimer's disease and related dementias and strategic implications for stakeholders. J Alzheimers Dis. 2019;70:323-341. https://doi.org/10.3233/JAD-190426
Lang L, Clifford A, Wei L, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017;7(2):e011146. Published 2017 Feb 3. https://doi.org/10.1136/bmjopen-2016-011146
White L, Ingraham B, Larson E, Fishman P, Park S, Coe NB. Observational study of patient characteristics associated with a timely diagnosis of dementia and mild cognitive impairment without dementia. J Gen Intern Med. 2022;37(12), 2957-2965. https://doi.org/10.1007/s11606-021-07169-7
Chin AL, Negash S, Hamilton R. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2011;25(3):187-195. https://doi.org/10.1097/WAD.0b013e318211c6c9
Lin PJ, Daly AT, Olchanski N, et al. Dementia diagnosis disparities by race and ethnicity. Med Care. 2021;59(8):679-686. https://doi.org/10.1097/MLR.0000000000001577
Fowler NR, Head KJ, Perkins AJ, et al. Examining the benefits and harms of Alzheimer's disease screening for family members of older adults: study protocol for a randomized controlled trial. Trials. 2020;21(1):202. https://doi.org/10.1186/s13063-019-4029-5
Petersen RC, Yaffe K. Issues and questions surrounding screening for cognitive impairment in older patients. JAMA. 2020;323(8):722-724. https://doi.org/10.1001/jama.2019.22527
Tong T, Thokala P, McMillan B, Ghosh R, Brazier J. Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care. Int J Geriatr Psychiatry. 2017;32:1392-1400. https://doi.org/10.1002/gps.4626
Rasmussen J, Langerman H. Alzheimer's disease-why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019;9:123-130. https://doi.org/10.2147/DNND.S228939
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
Van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2023;388:9-21. https://doi.org/10.1056/NEJMoa2212948
Mattke S, Wang M. Implications of Alzheimer's treatment for organization and payment of medical practices in the United States. USC Dornsife Center for Economic and Social Research; 2020. Last accessed December 2022: https://cesr.usc.edu/sites/default/files/Implications%20of%20Alzheimer%27s%20Treatment%20for%20Organization%20and%20Payment%20of%20Medical%20Practices%20in%20the%20United%20States%20%282020%29.pdf
Sabbagh MN, Boada M, Borson S, et al. Early detection of mild cognitive impairment (MCI) in primary care. J Prev Alzheimer's Dis. 2020;7(3). https://doi.org/10.14283/jpad.2020.21
Jacobson M, Thunell J, Zissimopoulos J. Cognitive assessment at Medicare's Annual Wellness Visit in fee-for-service and Medicare Advantage plans. Health Aff (Millwood). 2020;39(11):1935-1942. https://doi.org/10.1377/hlthaff.2019.01795
De Roeck EE, De Deyn PP, Dierckx E, Engelborghs, S. Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review. Alz Res Therapy. 2019;11:21. https://doi.org/10.1186/s13195-019-0474-3
Lam J, Hlavka J, Mattke S. The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey. J Am Board Fam Med. 2019;32(6):931-940. Last accessed December 2022: https://www.jabfm.org/content/jabfp/32/6/931.full.pdf
Lamar M, Lerner AJ, James BD, et al. Relationship of early-life residence and educational experience to level and change in cognitive functioning: results of the Minority Aging Research Study. J Gerontol B Psychol Sci Soc Sci. 2020;75(7):e81-e92. https://doi.org/10.1093/geronb/gbz031
Maserejian N, Krzywy H, Eaton S, Galvin JE. Cognitive measures lacking in electronic health record prior to dementia or Alzheimer's disease diagnosis. Alzheimers Dement. 2021;17(7):1231-1243.https://doi.org/10.1002/alz.12280
Fowler NR, Morrow LA, Chiappetta L, et al. Cognitive testing in older primary care patients: a cluster-randomized trial. Alzheimers Dement (Amst). 2015;1(3):349-357. https://doi.org/10.1016/j.dadm.2015.06.009
Ty D, McDermott M. Building workforce capacity to improve detection and diagnosis of dementia. Milken Institute; 2021. Last accessed December 2022: https://milkeninstitute.org/sites/default/files/2021-05/Building%20Dementia%20Workforce.pdf
Bernstein A, Rogers KM, Possin KL, et al. Dementia assessment and management in primary care settings: a survey of current provider practices in the United States. BMC Health Serv Res. 2019;19(1):919. https://doi.org/10.1186/s12913-019-4603-2
U.S. Preventive Services Task Force. Final recommendation statement: Cognitive Impairment in Older Adults: Screening. 2020. Last accessed December 2022: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening
Fowler NR, Perkins A, Gao A, Sachs G, Boustani MA. Risks and benefits of screening for dementia in primary care: the IU CHOICE trial. J Am Ger Soc. 2020;68:535-543. https://doi.org/10.1111/jgs.16247
Solomon PR, Murphy CA. Should we screen for Alzheimer's disease? a review of the evidence for and against screening for Alzheimer's disease in primary care practice. Geriatrics. 2005;60:26-31.
Knopman D, Donohue JA, Gutterman EM. Patterns of care in the early stages of Alzheimer's disease: impediments to timely diagnosis. J Am Geriatr Soc 2000;48(3):300-304. https://doi.org/10.1111/j.1532-5415.2000.tb02650.x
Sabbagh MN, Boada M, Borson S, et al. Rationale for early diagnosis of Mild Cognitive Impairment (MCI) supported by Emerging Digital Technologies. J Prev Alzheimers Dis. 2020;7:158-164. https://doi.org/10.14283/jpad.2020.19
Tsoy E, Sideman AB, Piña Escudero SD, et al. Global perspectives on brief cognitive assessments for dementia diagnosis. J Alzheimers Dis. 2021;82(3):1001-1013. https://doi.org/10.3233/JAD-201403
Shores MM, Ryan-Dykes P, Williams RM, et al. Identifying undiagnosed dementia in residential care veterans: comparing telemedicine to in-person clinical examination. Int J Geriatr Psychiatry. 2004;19(2):101-108. https://doi.org/10.1002/gps.1029
Wiese LK, Williams CL. Annual cognitive assessment for older adults: update for nurses. J Community Health Nurs. 2015;32(4):187-98. https://doi.org/10.1080/07370016.2015.1087244
Maserejian N, Krzywy H, Eaton S, Galvin JE. Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis. Alzheimer's Dement. 2021;17:1231-1243. https://doi.org/10.1002/alz.12280
Chen Z, Zhang H, Yang X, et al. Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer's disease and related dementias. Int J Med Inform. 2023;170,104973. https://doi.org/10.1016/j.ijmedinf.2022.104973
Heintz H, Monette P, Epstein-Lubow G, Smith L, Rowlett S, Forester BP. Emerging collaborative care models for dementia care in the primary care setting: a narrative review. Am J Geriatr Psychiatry. 2020;28(3):320-330. https://doi.org/10.1016/j.jagp.2019.07.015
National Academies of Sciences, Engineering, and Medicine. Meeting the challenge of caring for persons living with dementia and their care partners and caregivers: a way forward. National Academies Press; 2021. https://doi.org/10.17226/26026
Centers for Medicare & Medicaid Services. 42 CFR § 410.15: Annual wellness visits providing personalized prevention plan services: conditions for limitations on coverage [Internet]. CMS; 2011 Nov 28 [cited 2020 Sep 1]. Available from: https://www.govinfo.gov/content/pkg/CFR-2012-title42-vol2/pdf/CFR-2012-title42-vol2-sec410-15.pdf

Auteurs

Soeren Mattke (S)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Center for Improving Chronic Illness Care, University of Southern California, Los Angeles, California, USA.

Donnie Batie (D)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Baton Rouge General Medical Center, Baton Rouge, Louisiana, USA.

Joshua Chodosh (J)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York University School of Medicine, New York, New York, USA.
NYU School of Medicine, New York Harbor VA Healthcare System, New York, New York, USA.

Kristen Felten (K)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Wisconsin Department of Health Services, Office on Aging, Madison, Wisconsin, USA.

Ellen Flaherty (E)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Dartmouth Centers for Health and Aging, Geisel School of Medicine, Lebanon, New Hampshire, USA.

Nicole R Fowler (NR)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Indiana University Center for Aging Research, Indiana University School of Medicine and the Regenstrief Institute, Indianapolis, Indiana, USA.
Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Center for Health Innovation and Implementation Science, Indiana University, Indianapolis, Indiana, USA.

Fred A Kobylarz (FA)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Department of Family Medicine and Community Health, Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey, USA.

Kelly O'Brien (K)

UsAgainstAlzheimer's, Washington, District of Columbia, USA.

Russ Paulsen (R)

UsAgainstAlzheimer's, Washington, District of Columbia, USA.

Anne Pohnert (A)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
CVS Health MinuteClinic, Woonsocket, Rhode Island, USA.

Katherine L Possin (KL)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Department of Neurology, University of California, San Francisco Memory and Aging Center, San Francisco, California, USA.

Tatiana Sadak (T)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
University of Washington School of Nursing, Seattle, Washington, USA.

Diane Ty (D)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Alliance to Improve Dementia Care, Milken Institute Center for the Future of Aging, Washington, District of Columbia, USA.

Amy Walsh (A)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Age-Friendly Health Systems, Institute for Healthcare Improvement, Boston, Massachusetts, USA.

Julie M Zissimopoulos (JM)

Brief Cognitive Assessment Work Group, District of Columbia, USA.
Sol Price School of Public Policy, University of Southern California, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Expanding the use of brief cognitive...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Troubles de la cognition › Dysfonctionnement cognitif › Expanding the use of brief cognitive...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie d'Alzheimer › Expanding the use of brief cognitive...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Mode de vie › Expanding the use of brief cognitive...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Cognition › Expanding the use of brief cognitive...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Services de santé polyvalents › Soins de santé primaires › Expanding the use of brief cognitive...